The urgent need for designing greener drugs

Tomas Brodin; Michael G. Bertram; Kathryn E. Arnold; Alistair B.A. Boxall; Bryan W. Brooks; Daniel Cerveny; Manuela Jörg; Karen A. Kidd; Unax Lertxundi; Jake M. Martin; Lauren T. May; Erin S. McCallum; Marcus Michelangeli; Charles R. Tyler; Bob B.M. Wong; Klaus Kümmerer; Gorka Orive

doi:10.1038/s41893-024-01374-y

The urgent need for designing greener drugs

Tomas Brodin
, Michael G. Bertram
, Kathryn E. Arnold
, Alistair B.A. Boxall
, Bryan W. Brooks
, Daniel Cerveny
, Manuela Jörg
, Karen A. Kidd
, Unax Lertxundi
, Jake M. Martin
, Lauren T. May
, Erin S. McCallum
, Marcus Michelangeli
, Charles R. Tyler
, Bob B.M. Wong
, Klaus Kümmerer
, Gorka Orive

Research output: Contribution to journal › Comment / Debate › Other › peer-review

40 Citations (Scopus)

Abstract

The pervasive contamination of ecosystems with active pharmaceutical ingredients poses a serious threat to biodiversity, ecosystem services and public health. Urgent action is needed to design greener drugs that maintain efficacy but also minimize environmental impact.

Original language	English
Pages (from-to)	949–951
Number of pages	3
Journal	Nature Sustainability
Volume	7
DOIs	https://doi.org/10.1038/s41893-024-01374-y
Publication status	Published - 5 Jun 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being
SDG 7 Affordable and Clean Energy

Access to Document

10.1038/s41893-024-01374-y

Cite this

Brodin, T., Bertram, M. G., Arnold, K. E., Boxall, A. B. A., Brooks, B. W., Cerveny, D., Jörg, M., Kidd, K. A., Lertxundi, U., Martin, J. M., May, L. T., McCallum, E. S., Michelangeli, M., Tyler, C. R., Wong, B. B. M., Kümmerer, K., & Orive, G. (2024). The urgent need for designing greener drugs. Nature Sustainability, 7, 949–951. https://doi.org/10.1038/s41893-024-01374-y

@article{9960819c57a643139a192cde0a38b724,

title = "The urgent need for designing greener drugs",

abstract = "The pervasive contamination of ecosystems with active pharmaceutical ingredients poses a serious threat to biodiversity, ecosystem services and public health. Urgent action is needed to design greener drugs that maintain efficacy but also minimize environmental impact.",

author = "Tomas Brodin and Bertram, \{Michael G.\} and Arnold, \{Kathryn E.\} and Boxall, \{Alistair B.A.\} and Brooks, \{Bryan W.\} and Daniel Cerveny and Manuela J{\"o}rg and Kidd, \{Karen A.\} and Unax Lertxundi and Martin, \{Jake M.\} and May, \{Lauren T.\} and McCallum, \{Erin S.\} and Marcus Michelangeli and Tyler, \{Charles R.\} and Wong, \{Bob B.M.\} and Klaus K{\"u}mmerer and Gorka Orive",

note = "Funding Information: We acknowledge funding support from the Swedish Research Council Formas (2018-00828 to T.B., 2020-02293 to M.G.B., 2020-00981 to E.S.M., 2020-01052 to D.C., 2022-00503 to M.M. and 2022-02796/2023-01253 to J.M.M.), the Kempe Foundations (SMK-1954, SMK21-0069 and JCSMK23-0078 to M.G.B.), the Swedish Research Council VR (2022-03368 to E.S.M.), the European Union\textbackslash{}u2019s Horizon 2020 Research and Innovation Programme under the Marie Sk\textbackslash{}u0142odowska-Curie grant agreement (101061889 to M.M.), Research England (131911 to M.J.), the Spanish Ministry of Economy, Industry and Competitiveness (PID2022-139746OB-I00/AEI/10.13039/501100011033 to G.O.), the Australian Research Council (FT190100014 and DP220100245 to B.B.M.W.), the Jarislowsky Foundation (to K.A.K.), a Royal Society of New Zealand Catalyst Leaders Fellowship (ILF-CAW2201 to B.W.B.) and the National Institute of Environmental Health Sciences of the National Institutes of Health (1P01ES028942 to B.W.B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: {\textcopyright} Springer Nature Limited 2024.",

year = "2024",

month = jun,

day = "5",

doi = "10.1038/s41893-024-01374-y",

language = "English",

volume = "7",

pages = "949–951",

journal = "Nature Sustainability",

issn = "2398-9629",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - The urgent need for designing greener drugs

AU - Brodin, Tomas

AU - Bertram, Michael G.

AU - Arnold, Kathryn E.

AU - Boxall, Alistair B.A.

AU - Brooks, Bryan W.

AU - Cerveny, Daniel

AU - Jörg, Manuela

AU - Kidd, Karen A.

AU - Lertxundi, Unax

AU - Martin, Jake M.

AU - May, Lauren T.

AU - McCallum, Erin S.

AU - Michelangeli, Marcus

AU - Tyler, Charles R.

AU - Wong, Bob B.M.

AU - Kümmerer, Klaus

AU - Orive, Gorka

N1 - Funding Information: We acknowledge funding support from the Swedish Research Council Formas (2018-00828 to T.B., 2020-02293 to M.G.B., 2020-00981 to E.S.M., 2020-01052 to D.C., 2022-00503 to M.M. and 2022-02796/2023-01253 to J.M.M.), the Kempe Foundations (SMK-1954, SMK21-0069 and JCSMK23-0078 to M.G.B.), the Swedish Research Council VR (2022-03368 to E.S.M.), the European Union\u2019s Horizon 2020 Research and Innovation Programme under the Marie Sk\u0142odowska-Curie grant agreement (101061889 to M.M.), Research England (131911 to M.J.), the Spanish Ministry of Economy, Industry and Competitiveness (PID2022-139746OB-I00/AEI/10.13039/501100011033 to G.O.), the Australian Research Council (FT190100014 and DP220100245 to B.B.M.W.), the Jarislowsky Foundation (to K.A.K.), a Royal Society of New Zealand Catalyst Leaders Fellowship (ILF-CAW2201 to B.W.B.) and the National Institute of Environmental Health Sciences of the National Institutes of Health (1P01ES028942 to B.W.B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: © Springer Nature Limited 2024.

PY - 2024/6/5

Y1 - 2024/6/5

N2 - The pervasive contamination of ecosystems with active pharmaceutical ingredients poses a serious threat to biodiversity, ecosystem services and public health. Urgent action is needed to design greener drugs that maintain efficacy but also minimize environmental impact.

AB - The pervasive contamination of ecosystems with active pharmaceutical ingredients poses a serious threat to biodiversity, ecosystem services and public health. Urgent action is needed to design greener drugs that maintain efficacy but also minimize environmental impact.

UR - https://www.scopus.com/pages/publications/85195401032

U2 - 10.1038/s41893-024-01374-y

DO - 10.1038/s41893-024-01374-y

M3 - Comment / Debate

AN - SCOPUS:85195401032

SN - 2398-9629

VL - 7

SP - 949

EP - 951

JO - Nature Sustainability

JF - Nature Sustainability

ER -

The urgent need for designing greener drugs

Abstract

UN SDGs

Access to Document

Other files and links

Endocrine disruption in wildlife: a sexual selection perspective

How drugs in the wild affect animal behaviour, ecosystems, and evolution

Cite this

The urgent need for designing greener drugs

Abstract

UN SDGs

Access to Document

Other files and links

Projects

Endocrine disruption in wildlife: a sexual selection perspective

How drugs in the wild affect animal behaviour, ecosystems, and evolution

Cite this